Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
Status:
Completed
Trial end date:
2008-11-27
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics in
patients with osteoarthritic pain of the knee. The most painful knee joint will be identified
as the index joint at screening, and this joint will be used for all pain assessments
throughout the study.